Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Equity Income: 2010-2015

Historic Equity Income for Cryo Cell International (CCEL) over the last 6 years, with Q4 2015 value amounting to -$1164.0.

  • Cryo Cell International's Equity Income rose 9903.46% to -$1164.0 in Q4 2015 from the same period last year, while for May 2016 it was -$1164.0, marking a year-over-year increase of 9919.9%. This contributed to the annual value of -$18824.0 for FY2015, which is 9481.27% up from last year.
  • As of Q4 2015, Cryo Cell International's Equity Income stood at -$1164.0, which was up 9903.46% from -$1164.0 recorded in Q3 2015.
  • Cryo Cell International's Equity Income's 5-year high stood at -$1164.0 during Q3 2015, with a 5-year trough of -$134802.0 in Q4 2011.
  • Moreover, its 5-year median value for Equity Income was -$38450.0 (2012), whereas its average is -$45867.0.
  • As far as peak fluctuations go, Cryo Cell International's Equity Income plummeted by 21254.15% in 2014, and later soared by 9903.46% in 2015.
  • Over the past 5 years, Cryo Cell International's Equity Income (Quarter) stood at -$134802.0 in 2011, then skyrocketed by 71.48% to -$38450.0 in 2012, then fell by 0.33% to -$38576.0 in 2013, then tumbled by 212.54% to -$120566.0 in 2014, then surged by 99.03% to -$1164.0 in 2015.
  • Its Equity Income was -$1164.0 in Q4 2015, compared to -$1164.0 in Q3 2015 and -$8248.0 in Q2 2015.